You are here
Nobivac® Pi, Lyophilisate and Solvent for Suspension for Injection for Dogs
Canine parainfluenza virus is one of the significant causes of canine infectious respiratory disease ((CIRD) commonly referred to as kennel cough or canine cough) and is recommended for dogs that are regularly mixed or regularly come into contact with other dogs (e.g. kennelling, boarding, dog training etc.). It may cause disease in its own right or in association with other respiratory pathogens to cause more severe signs. The disease is highly infectious and transmitted readily by aerosols (coughing or sneezing). Nobivac® Pi is most often used as an annual booster vaccine for Nobivac DHPPi® in interim years when immunity to distemper, hepatitis and parvovirus (DHP) is not needed. It is recommended that canine parainfluenza vaccination is used in association with vaccination against Bordetella bronchiseptica, such as Nobivac® Respira Bb, or alternatively Nobivac® KC could be used, which immunises against both Bordetella bronchiseptica and canine parainfluenza virus. Information on the importance of these pathogens can be found here.
Presentation
Off-white or cream-coloured lyophilisate and clear colourless solvent for suspension for injection. Reconstituted product: off-pink or pink suspension.
Active ingredients
1 dose of 1 ml contains:
Live attenuated canine parainfluenza virus (CPi) strain Cornell: ≥ 5.5 log10 and ≤ 7.3 log10 TCID50*
*TCID50= median Tissue Culture Infective Dose
Target species
Dogs.
Indications for use
For active immunisation of dogs from the age of 8 weeks onwards to reduce clinical signs of canine parainfluenza infection and to reduce viral shedding.
Onset of immunity: 4 weeks after vaccination.
Duration of immunity: has not been demonstrated, but an anamnestic response is produced in dogs given a revaccination one year after basic vaccination.
Annual booster vaccination is recommended for dogs who regularly socialise or are kennelled with other dogs (e.g. boarding, dog training).
Packaging
Plastic box with 10 or 50 single dose vials.
Legal category
POM-V
For full information please refer to the product data sheet. Further information is available on request.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Use Medicines Responsibly.
Date of preparation: September 2023
Nobivac® Respira Bb is an inactivated subunit vaccine containing the fimbrial antigen of Bordetella bronchiseptica. POM-V.
Nobivac® DHPPi contains live canine distemper virus (strain Onderstepoort), canine adenovirus type 2 (strain Manhattan LPV3), canine parvovirus (strain 154) and canine parainfluenza virus (strain Cornell). POM-V.
Nobivac® KC contains live Bordetella bronchiseptica bacteria (strain B-C2) and canine parainfluenza virus (strain Cornell). POM-V.
MSD Animal Health UK Limited. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942.
Advice should be sought from the medicine prescriber.
Use Medicines Responsibly.